CN Stock MarketDetailed Quotes

300482 Guangzhou Wondfo Biotech

Watchlist
  • 20.03
  • -0.38-1.86%
Market Closed Sep 13 15:00 CST
9.64BMarket Cap18.95P/E (TTM)

Guangzhou Wondfo Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
5.82%1.58B
3.54%861.09M
-51.33%2.76B
-57.32%2B
-63.09%1.49B
-68.32%831.63M
69.01%5.68B
87.32%4.7B
117.30%4.03B
276.87%2.63B
Operating revenue
5.82%1.58B
3.54%861.09M
-51.33%2.76B
-57.32%2B
-63.09%1.49B
-68.32%831.63M
69.01%5.68B
87.32%4.7B
117.30%4.03B
276.87%2.63B
Other operating revenue
-50.13%1.92M
----
-24.25%5.22M
----
-41.70%3.85M
----
-3.11%6.89M
----
38.95%6.6M
----
Total operating cost
3.35%1.18B
0.28%609.78M
-47.01%2.29B
-51.44%1.62B
-57.58%1.15B
-59.46%608.06M
57.09%4.33B
75.23%3.33B
112.25%2.7B
182.13%1.5B
Operating cost
3.53%561.7M
0.54%290.15M
-62.22%1.03B
-65.58%744.9M
-69.04%542.55M
-69.54%288.59M
96.02%2.74B
151.46%2.16B
202.20%1.75B
361.11%947.56M
Operating tax surcharges
22.26%5.17M
48.62%3.04M
-31.63%12.17M
-47.30%5.63M
-50.56%4.23M
-42.78%2.04M
77.41%17.8M
58.25%10.69M
70.24%8.55M
34.24%3.57M
Operating expense
0.95%318.5M
9.45%159.81M
-30.08%649.99M
-30.87%465.93M
-43.47%315.5M
-58.21%146.02M
44.28%929.61M
24.42%673.97M
53.54%558.11M
101.00%349.41M
Administration expense
1.07%107.38M
-8.68%58.49M
-0.32%227.13M
-23.38%150.73M
-29.74%106.24M
-12.89%64.05M
-14.32%227.85M
5.56%196.72M
24.46%151.23M
16.88%73.53M
Financial expense
56.70%-5.8M
-155.96%-7.25M
-817.68%-6.41M
60.48%-11.3M
-88.51%-13.39M
67.60%12.96M
-101.43%-697.96K
-209.34%-28.59M
-132.07%-7.1M
85.74%7.73M
-Interest expense (Financial expense)
2.58%15.09M
-10.42%7.14M
-7.99%29.93M
-4.81%21.49M
-0.04%14.71M
6.85%7.98M
17.21%32.53M
4.79%22.58M
3.27%14.71M
7.02%7.46M
-Interest Income (Financial expense)
-45.93%-13.18M
-108.50%-5.27M
-435.67%-27.61M
-265.23%-15.19M
-121.92%-9.03M
-224.51%-2.53M
-70.87%-5.15M
-150.37%-4.16M
-205.02%-4.07M
-13.94%-779.41K
Research and development
3.45%197.31M
11.80%105.55M
-9.75%378M
-16.14%259.47M
-19.91%190.74M
-20.18%94.4M
7.09%418.84M
11.85%309.4M
31.82%238.15M
43.13%118.28M
Credit Impairment Loss
-845.04%-15.27M
-368.29%-8.46M
92.91%-1.5M
92.74%-885.39K
85.44%-1.62M
97.79%-1.81M
4.18%-21.14M
8.93%-12.2M
10.97%-11.1M
-1,027.87%-81.85M
Asset Impairment Loss
----
----
85.41%-11.52M
----
----
----
-1,244.43%-78.97M
----
----
----
Other net revenue
-64.29%16.23M
-88.63%962.56K
357.37%78.88M
13.06%73.72M
27.21%45.45M
110.99%8.47M
-80.23%17.25M
-19.05%65.2M
-36.55%35.73M
-797.67%-77.04M
Fair value change income
5,272.86%15.57M
--867.58K
15.51%14.8M
281.58%14.23M
-98.04%289.84K
----
21.42%12.81M
--3.73M
--14.81M
----
Invest income
-105.45%-1.21M
81.08%2.96M
-47.97%31.1M
-23.74%26.48M
83.34%22.22M
-39.81%1.63M
25.92%59.77M
-27.69%34.72M
-60.16%12.12M
-69.12%2.71M
-Including: Investment income associates
-580.74%-7.34M
-669.69%-3M
-233.77%-4.33M
-2,264.09%-3.06M
73.99%-1.08M
66.39%-390.3K
156.38%3.24M
-96.20%141.57K
-248.87%-4.14M
-194.79%-1.16M
Asset deal income
----
----
100.77%80.14K
-8,757.56%-55.22K
-4,937.69%-55.22K
---59.91K
-183,304.02%-10.4M
-99.68%637.85
-99.28%1.14K
----
Other revenue
-30.32%17.14M
-35.62%5.6M
-16.77%45.92M
-12.83%33.95M
23.68%24.6M
315.37%8.7M
-3.45%55.17M
-14.82%38.95M
-47.91%19.89M
-77.98%2.1M
Operating profit
4.90%407.22M
8.72%252.27M
-59.85%549.14M
-67.76%462.77M
-71.63%388.22M
-77.86%232.04M
97.68%1.37B
108.18%1.44B
113.82%1.37B
495.71%1.05B
Add:Non operating Income
-44.42%705.83K
-65.58%228.83K
16.58%3.55M
126.48%2.12M
168.03%1.27M
10.43%664.73K
8.17%3.04M
-6.61%935.96K
-41.79%473.82K
39.19%601.92K
Less:Non operating expense
-10.66%2.58M
-24.54%897.9K
90.81%11.92M
-11.85%5.4M
0.41%2.89M
31.16%1.19M
-56.07%6.25M
43.14%6.13M
4.51%2.88M
55.44%907.22K
Total profit
4.85%405.35M
8.68%251.6M
-60.37%540.76M
-67.87%459.49M
-71.70%386.6M
-77.91%231.51M
100.52%1.36B
108.42%1.43B
114.10%1.37B
496.05%1.05B
Less:Income tax cost
-12.54%47.03M
6.35%31.16M
-69.42%53.33M
-68.39%61.8M
-71.82%53.77M
-79.95%29.3M
264.04%174.41M
228.27%195.48M
138.34%190.8M
525.74%146.15M
Net profit
7.66%358.31M
9.02%220.44M
-59.04%487.43M
-67.79%397.69M
-71.68%332.82M
-77.57%202.21M
88.14%1.19B
97.03%1.23B
110.62%1.18B
491.50%901.71M
Net profit from continuing operation
7.66%358.31M
9.02%220.44M
-58.74%491.01M
-67.79%397.69M
-71.68%332.82M
-77.57%202.21M
83.81%1.19B
97.03%1.23B
110.62%1.18B
491.50%901.71M
Net income from discontinuing operating
----
----
---3.58M
----
----
----
----
----
----
----
Less:Minority Profit
249.68%2.51M
243.94%2.11M
97.17%-196.42K
60.16%-2.12M
41.13%-1.68M
18.45%-1.47M
-274.78%-6.94M
-697.92%-5.33M
-227.87%-2.85M
39.63%-1.8M
Net profit of parent company owners
6.37%355.8M
7.20%218.33M
-59.26%487.62M
-67.75%399.81M
-71.60%334.5M
-77.46%203.68M
88.68%1.2B
97.67%1.24B
111.98%1.18B
481.32%903.51M
Earning per share
Basic earning per share
2.63%0.78
6.52%0.49
-59.41%1.1
-67.62%0.91
-71.54%0.76
-77.56%0.46
89.51%2.71
97.89%2.81
111.90%2.67
485.71%2.05
Diluted earning per share
2.63%0.78
6.52%0.49
-59.41%1.1
-67.62%0.91
-71.54%0.76
-77.56%0.46
89.51%2.71
97.89%2.81
111.90%2.67
485.71%2.05
Other composite income
-61.49%736.51K
5.66%413.48K
-151.84%-109.99M
-79.64%2.22M
-57.68%1.91M
-80.12%391.33K
-223.20%-43.67M
2,422.29%10.89M
789.91%4.52M
264.77%1.97M
Other composite income of parent company owners
-61.49%736.51K
5.66%413.48K
-151.84%-109.99M
-79.64%2.22M
-57.68%1.91M
-80.12%391.33K
-223.20%-43.67M
2,422.29%10.89M
789.91%4.52M
264.77%1.97M
Total composite income
7.26%359.05M
9.01%220.86M
-67.08%377.44M
-67.89%399.9M
-71.62%334.74M
-77.58%202.6M
71.62%1.15B
98.92%1.25B
111.68%1.18B
490.70%903.68M
Total composite income of parent company owners
5.98%356.54M
7.19%218.75M
-67.26%377.64M
-67.86%402.03M
-71.55%336.42M
-77.46%204.07M
72.18%1.15B
99.56%1.25B
113.04%1.18B
480.57%905.48M
Total composite income of minority owners
249.68%2.51M
243.94%2.11M
97.17%-196.42K
60.16%-2.12M
41.13%-1.68M
18.45%-1.47M
-274.78%-6.94M
-697.92%-5.33M
-227.87%-2.85M
39.63%-1.8M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 5.82%1.58B3.54%861.09M-51.33%2.76B-57.32%2B-63.09%1.49B-68.32%831.63M69.01%5.68B87.32%4.7B117.30%4.03B276.87%2.63B
Operating revenue 5.82%1.58B3.54%861.09M-51.33%2.76B-57.32%2B-63.09%1.49B-68.32%831.63M69.01%5.68B87.32%4.7B117.30%4.03B276.87%2.63B
Other operating revenue -50.13%1.92M-----24.25%5.22M-----41.70%3.85M-----3.11%6.89M----38.95%6.6M----
Total operating cost 3.35%1.18B0.28%609.78M-47.01%2.29B-51.44%1.62B-57.58%1.15B-59.46%608.06M57.09%4.33B75.23%3.33B112.25%2.7B182.13%1.5B
Operating cost 3.53%561.7M0.54%290.15M-62.22%1.03B-65.58%744.9M-69.04%542.55M-69.54%288.59M96.02%2.74B151.46%2.16B202.20%1.75B361.11%947.56M
Operating tax surcharges 22.26%5.17M48.62%3.04M-31.63%12.17M-47.30%5.63M-50.56%4.23M-42.78%2.04M77.41%17.8M58.25%10.69M70.24%8.55M34.24%3.57M
Operating expense 0.95%318.5M9.45%159.81M-30.08%649.99M-30.87%465.93M-43.47%315.5M-58.21%146.02M44.28%929.61M24.42%673.97M53.54%558.11M101.00%349.41M
Administration expense 1.07%107.38M-8.68%58.49M-0.32%227.13M-23.38%150.73M-29.74%106.24M-12.89%64.05M-14.32%227.85M5.56%196.72M24.46%151.23M16.88%73.53M
Financial expense 56.70%-5.8M-155.96%-7.25M-817.68%-6.41M60.48%-11.3M-88.51%-13.39M67.60%12.96M-101.43%-697.96K-209.34%-28.59M-132.07%-7.1M85.74%7.73M
-Interest expense (Financial expense) 2.58%15.09M-10.42%7.14M-7.99%29.93M-4.81%21.49M-0.04%14.71M6.85%7.98M17.21%32.53M4.79%22.58M3.27%14.71M7.02%7.46M
-Interest Income (Financial expense) -45.93%-13.18M-108.50%-5.27M-435.67%-27.61M-265.23%-15.19M-121.92%-9.03M-224.51%-2.53M-70.87%-5.15M-150.37%-4.16M-205.02%-4.07M-13.94%-779.41K
Research and development 3.45%197.31M11.80%105.55M-9.75%378M-16.14%259.47M-19.91%190.74M-20.18%94.4M7.09%418.84M11.85%309.4M31.82%238.15M43.13%118.28M
Credit Impairment Loss -845.04%-15.27M-368.29%-8.46M92.91%-1.5M92.74%-885.39K85.44%-1.62M97.79%-1.81M4.18%-21.14M8.93%-12.2M10.97%-11.1M-1,027.87%-81.85M
Asset Impairment Loss --------85.41%-11.52M-------------1,244.43%-78.97M------------
Other net revenue -64.29%16.23M-88.63%962.56K357.37%78.88M13.06%73.72M27.21%45.45M110.99%8.47M-80.23%17.25M-19.05%65.2M-36.55%35.73M-797.67%-77.04M
Fair value change income 5,272.86%15.57M--867.58K15.51%14.8M281.58%14.23M-98.04%289.84K----21.42%12.81M--3.73M--14.81M----
Invest income -105.45%-1.21M81.08%2.96M-47.97%31.1M-23.74%26.48M83.34%22.22M-39.81%1.63M25.92%59.77M-27.69%34.72M-60.16%12.12M-69.12%2.71M
-Including: Investment income associates -580.74%-7.34M-669.69%-3M-233.77%-4.33M-2,264.09%-3.06M73.99%-1.08M66.39%-390.3K156.38%3.24M-96.20%141.57K-248.87%-4.14M-194.79%-1.16M
Asset deal income --------100.77%80.14K-8,757.56%-55.22K-4,937.69%-55.22K---59.91K-183,304.02%-10.4M-99.68%637.85-99.28%1.14K----
Other revenue -30.32%17.14M-35.62%5.6M-16.77%45.92M-12.83%33.95M23.68%24.6M315.37%8.7M-3.45%55.17M-14.82%38.95M-47.91%19.89M-77.98%2.1M
Operating profit 4.90%407.22M8.72%252.27M-59.85%549.14M-67.76%462.77M-71.63%388.22M-77.86%232.04M97.68%1.37B108.18%1.44B113.82%1.37B495.71%1.05B
Add:Non operating Income -44.42%705.83K-65.58%228.83K16.58%3.55M126.48%2.12M168.03%1.27M10.43%664.73K8.17%3.04M-6.61%935.96K-41.79%473.82K39.19%601.92K
Less:Non operating expense -10.66%2.58M-24.54%897.9K90.81%11.92M-11.85%5.4M0.41%2.89M31.16%1.19M-56.07%6.25M43.14%6.13M4.51%2.88M55.44%907.22K
Total profit 4.85%405.35M8.68%251.6M-60.37%540.76M-67.87%459.49M-71.70%386.6M-77.91%231.51M100.52%1.36B108.42%1.43B114.10%1.37B496.05%1.05B
Less:Income tax cost -12.54%47.03M6.35%31.16M-69.42%53.33M-68.39%61.8M-71.82%53.77M-79.95%29.3M264.04%174.41M228.27%195.48M138.34%190.8M525.74%146.15M
Net profit 7.66%358.31M9.02%220.44M-59.04%487.43M-67.79%397.69M-71.68%332.82M-77.57%202.21M88.14%1.19B97.03%1.23B110.62%1.18B491.50%901.71M
Net profit from continuing operation 7.66%358.31M9.02%220.44M-58.74%491.01M-67.79%397.69M-71.68%332.82M-77.57%202.21M83.81%1.19B97.03%1.23B110.62%1.18B491.50%901.71M
Net income from discontinuing operating -----------3.58M----------------------------
Less:Minority Profit 249.68%2.51M243.94%2.11M97.17%-196.42K60.16%-2.12M41.13%-1.68M18.45%-1.47M-274.78%-6.94M-697.92%-5.33M-227.87%-2.85M39.63%-1.8M
Net profit of parent company owners 6.37%355.8M7.20%218.33M-59.26%487.62M-67.75%399.81M-71.60%334.5M-77.46%203.68M88.68%1.2B97.67%1.24B111.98%1.18B481.32%903.51M
Earning per share
Basic earning per share 2.63%0.786.52%0.49-59.41%1.1-67.62%0.91-71.54%0.76-77.56%0.4689.51%2.7197.89%2.81111.90%2.67485.71%2.05
Diluted earning per share 2.63%0.786.52%0.49-59.41%1.1-67.62%0.91-71.54%0.76-77.56%0.4689.51%2.7197.89%2.81111.90%2.67485.71%2.05
Other composite income -61.49%736.51K5.66%413.48K-151.84%-109.99M-79.64%2.22M-57.68%1.91M-80.12%391.33K-223.20%-43.67M2,422.29%10.89M789.91%4.52M264.77%1.97M
Other composite income of parent company owners -61.49%736.51K5.66%413.48K-151.84%-109.99M-79.64%2.22M-57.68%1.91M-80.12%391.33K-223.20%-43.67M2,422.29%10.89M789.91%4.52M264.77%1.97M
Total composite income 7.26%359.05M9.01%220.86M-67.08%377.44M-67.89%399.9M-71.62%334.74M-77.58%202.6M71.62%1.15B98.92%1.25B111.68%1.18B490.70%903.68M
Total composite income of parent company owners 5.98%356.54M7.19%218.75M-67.26%377.64M-67.86%402.03M-71.55%336.42M-77.46%204.07M72.18%1.15B99.56%1.25B113.04%1.18B480.57%905.48M
Total composite income of minority owners 249.68%2.51M243.94%2.11M97.17%-196.42K60.16%-2.12M41.13%-1.68M18.45%-1.47M-274.78%-6.94M-697.92%-5.33M-227.87%-2.85M39.63%-1.8M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data